VC  MB Venture Partners

http://www.mbventures.com





     Office Locations:

17 West Pontotoc Ave, Suite 101
Memphis, TN 38103
Phone: 901-322-0330
Fax: 901-322-0339

 

Stages:

  • Early
  • Expansion
  • Growth
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    MB Venture Partners provides private equity capital for growing life sciences companies. Founded in 2001, the firm's first fund, Memphis Biomed Ventures, attracted investment capital of $22.4 million. A second fund followed in 2005 bringing the firm's total under management to $76 million. MB invests in seed or early-stage financings, but selected later-stage financings will also be considered. The firm will invest only in biotechnology and medical device companies, and is especially interested in product solutions for musculoskeletal disease. MB invests in musculoskeletal ideas across the United States and non-musculoskeletal investments in the Southeast or Midwest. The firm is a participant in the TNInvestco Program (see profile) since 2010.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Gary D. Stevenson Managing Partner

     

    Portfolio companies include:


      Bionnovations
        web link


      BioSet
        web link


      CaloSyn Pharma
        web link


      Cayenne Medical
        web link


      Expanding Orthopedics
        web link


      Focal Point Pharmaceuticals


      Hapten Sciences
        web link


      iScreen Vision
        web link


      Kereos
        web link


      KFx Medical
        web link


      MB Innovations
        web link


      Ortho Kinematics
        web link


      Protein Discovery
        web link


      Restore
        web link


      Spine Wave
        web link


      Veracity Medical
        web link


      Visioneering Technologies
        web link


      Zyga
        web link


     

    Recent News: